FI
GNCA

Fosun International’s Genocea Biosciences, Inc. GNCA Stock Holding History

Fosun International’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-71,379
Closed -$345K – 333
2019
Q1 		$345K Buy
71,379
+20,919
+41% +$103K 0.02% 245
2018
Q4 		$119K Hold
50,460
– – 0.01% 288
2018
Q3 		$323K Buy
+50,460
New +$266K 0.02% 204

Other funds holding GNCA

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Fosun International's GNCA Position: Q2 2019 in Review

Fosun International sold out of Genocea Biosciences, Inc. (GNCA) in Q2 2019, closing a stake of 71,379 shares — an estimated $345K sold.

Fosun International first reported a position in GNCA in Q3 2018 and held it in 3 quarters. The position peaked at $345K in Q1 2019. 45 funds tracked by Wall St. Rank hold GNCA as of Q2 2019.

  • Fosun International reported no remaining Genocea Biosciences, Inc. position as of Q2 2019 after selling out during the quarter.
  • Fosun International sold 71,379 Genocea Biosciences, Inc. shares in Q2 2019, an estimated $345K.
  • Fosun International first reported a position in Genocea Biosciences, Inc. in Q3 2018 and held it in 3 quarters.
  • Fosun International's Genocea Biosciences, Inc. position peaked at $345K in Q1 2019.
  • 45 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q2 2019.

Based on Fosun International's 13F filing for Q2 2019, filed 12 Aug 2019.